Roundtable Discussion – Designing Effective TRP Targets by Exploring Emerging Clinical Candidates & Lessons from Other Targeted Therapies

10:00 am - Tuesday 21st July 2026

Join your colleagues for a deep-dive discussion in smaller groups to map out the next generation of TRP targets. You will brainstorm high-potential clinical candidates and cross-pollinate ideas from the ADC space to sharpen selection strategy before sharing your table’s thoughts and discussion back to the group.

  • Identifying optimal tumor targets by evaluating density, internalization, and off-target risk
  • Exploring current targets under development and their potential clinical impact
  • Applying lessons from antibody-drug conjugates and other targeted therapies to guide RLT target selection

Speakers:

Head of Corporate Development & Radiopharma Medical & Health; Sales; Operations
Affibody AB
Chief Financial Officer
Oncoinvent AS